Download | < Back |
18 Oct 2017 | |
The Statement of Investors Complaints for the Quarter ended 30th September, 2017 in accordance with Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is attached herewith.<BR> <BR> | |
View all announcements for PARENTERAL DRUGS (INDIA) LTD. | Source: BSE India |